Our technology is revolutionizing radiology. We’d love to work with you to help create better outcomes for patients everywhere.
We created the first FDA-cleared device supports concurrent reading, allowing for faster reading with proven, superior, automatic nodule detection.
Our four FDA-cleared applications are designed to improve reading efficiency and accuracy across the hospital enterprise without requiring additional hardware.
Riverain’s deep learning AI technology is FDA cleared, field tested, and clinically proven to provide real results in radiology.
Riverain Technologies advanced AI imaging software is in use by leading healthcare organizations around the world.
Peer reviews, reference accounts, and independent studies confirm that ClearRead technology is positively impacting the field of radiology.
We are happy to welcome Ofer Pinhasi as our new chief product officer. He will be responsible for the development and deployment of Riverain Technologies’ products in world markets, establishing governance processes, and leading the strategic planning effort to achieve business goals.
Pinhasi is an entrepreneurial and business-minded engineering and product leader, with a unique blend of global experience in technology-intensive, FDA-regulated software, and medical device innovation. He has a strong track record of strategically planning and delivering products that yield best-in-class business results. He has extensive experience working at companies in the clinical artificial intelligence industry in various leadership roles.
He earned his M.B.A. in marketing and technology, and his B.S. in computer sciences and mathematics from Tel Aviv University.